INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 37 filers reported holding INMUNE BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Financial Advocates Investment Management | 235,961 | $1,239,000 | 0.12% |
| FNY Investment Advisers, LLC | 1,000 | $5,000 | 0.00% |
| TRUE Private Wealth Advisors | 1,000 | $5,000 | 0.00% |
| Rockefeller Capital Management L.P. | 50 | $0 | 0.00% |
| Covington Capital Management | 1,000 | $5,000 | 0.00% |
| BlackRock Inc. | 18,802 | $98,000 | 0.00% |
| JPMORGAN CHASE & CO | 3 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,355 | $7,000 | 0.00% |
| DEUTSCHE BANK AG\ | 96,048 | $504,000 | 0.00% |
| ROYAL BANK OF CANADA | 101 | $1,000 | 0.00% |